Fritextsökning
Artiklar per år
Innehållstyper
-
Partial court victory for entrepreneur who lost his company
Swedish life science entrepreneur Mikael Kubista has won the first round against a law firm that he, along with other co-owners, sued for negligent advice in connection with losing his company, Tataa Biocenter.
-
Brådska på myndigheter inför nya EU-regler
Korta tidsramar och begränsade resurser. Det är några av utmaningarna som identifierats när tre myndigheter har utrett hur HTA-förordningen kan införas effektivt i Sverige.
-
600 million SEK for life science - "Should not be the country of moderation"
Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.
-
Bredd och spets på välbesökt life science-event
Hela kedjan inom läkemedelsframställning – från den tidiga forskningen till fyllning av vialer – var representerad när konferensen New Horizons in Biologics & Bioprocessing ägde rum på torsdagen.
-
“Research is always a lot of failures and a few successes”
Johan Rockberg at KTH Royal Institute of Technology in Stockholm.
-
Roche’s Genentech terminates licencing deal with Norwegian biotech
Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.
-
The new Swedish life science strategy – “It will consolidate Sweden as a leader”
Clinical trials and precision health are emphasised as key areas in the new national life science strategy.
-
A new life science cluster formed – “We are very strong in talent”
Stockholm and Uppsala’s joint life science cluster aims to be among the best in Europe. Pontus Holm, Life Science Coordinator for Region Stockholm, says the decision to create a joint profile for the two cities is strongly supported. He mentions that around 50 stakeholders were asked last winter if they were in favour of a joint cluster and that “the answer was a resounding yes”.
-
Medicinpriset till forskare som upptäckte mikro-RNA:s roll i genreglering
Årets Nobelpris i fysiologi eller medicin går till Victor Ambros och Gary Ruvkun för deras upptäckter om användningen av mikro-RNA inom posttransitionell genreglering.
-
From lab to patient – the art of developing new antibody therapies
For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along for much of the journey and has experienced setbacks, but also huge discoveries. “It’s amazing when you succeed,” she says.
-
Sobi announces agreement with Enable Injections
Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.
-
Artificial intelligence in radiology – “Risk prediction is very exciting”
A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiology at Lund University, radiology is a field that is well suited to the technology.
-
Biotech-entreprenör och sci-fi-författare – ”För att koppla av började jag skriva”
Han har grundat Lundabolaget Iconovo, författat en trilogi sci-fi-deckare och drömmer om en Netflix-serie baserad på hans egna böcker. ”Det roligaste är att ta en idé och realisera den” säger Orest Lastow.
-
Lista: Bäst betalda toppcheferna inom medtech
Det blåser på toppen i medtechvärlden – men belöningen är fortfarande avsevärd för dem som lyckas hålla sig kvar. Här är topplistan över de högst betalda vd:arna i branschen.
-
Ny vd för Voc Diagnostics
Voc Diagnostics internrekryterar. Lotta Tollstoy Tegler som idag är ansvarig för kvalitets- och regulatoriska frågor är bolagets nya vd.
-
Nytt namn till Pixelgens vetenskapliga råd
Pixelgen har tillsatt Mostafa Ronaghi till sitt vetenskapliga råd.
-
Astra Zeneca fick Swecares exportpris – ”Fenomenalt stark utveckling”
Ett globalt storbolag och en uppstickare delar på Swecare Export Awards 2024. Årets vinnare: läkemedelsjätten Astra Zeneca och sårvårdsbolaget PU sensor.
-
The Covid pandemic accelerated the development of cancer vaccine
The Covid pandemic gave a major boost to the vaccine field. The Danish biotech company Expres2ion Biotechnologies, which is developing a vaccine against breast cancer, testifies to this.
-
Coronapandemin påskyndade utveckling av cancervaccin
Coronapandemin gav ett stort uppsving för vaccinfältet. Det vittnar danska biotechbolaget Expres2ion Biotechnologies om, som utvecklar ett vaccin mot bröstcancer.
-
Venom from the deathstalker carries radiopharmaceuticals to the brain
In order to target cancerous brain tumours with radionuclides, the problematic blood-brain barrier must first be crossed. Life Science Sweden has visited a KI researcher who is trialling an unusual approach ‒ using scorpion venom.
-
“What is important is to create an overview and understanding from different perspectives”
Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diagnostics of the Future event.
-
To build trust, one must be able to say “I don’t know” – whether human or AI
Will AI strengthen or break down trust? It depends on whether we can understand and accept its limitations, and our own, writes Sarah Lidé in a column.
-
KI’s new super machine measures brain activity in real-time – “A very expensive hairdo”
Using brand-new, super-advanced equipment, researchers at Karolinska Institutet can now measure brain activity in real-time, with higher resolution than previously possible. “This opens up fantastic opportunities”, says brain researcher Daniel Lundqvist.
-
Rekordmånga biotech-konkurser i USA
Fjolåret var tufft för många företag inom biotech. I USA var antalet konkurser i branschen det högsta sedan 2010, visar en sammanställning.
BREAKING